| Q33280426 | A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation |
| Q45054904 | Antibiotic sensitivity of bacteria on the oral mucosa after hematopoietic cell transplantation |
| Q51691058 | Bacterial substitution of coagulase-negative staphylococci for streptococci on the oral mucosa after hematopoietic cell transplantation. |
| Q33865381 | Chemotherapy-induced oral mucositis in a patient with acute lymphoblastic leukaemia |
| Q34150143 | Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis |
| Q37661792 | Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation |
| Q36873829 | Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial |
| Q36921301 | Measurement of oral mucositis in children: a review of the literature |
| Q43547339 | Oral mucositis in patients receiving reduced-intensity regimens for allogeneic hematopoietic cell transplantation: comparison with conventional regimen |
| Q35755733 | Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients |
| Q45254400 | Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation |
| Q74769085 | Scoring oral mucositis |
| Q52726957 | Unusual oral mucosal microbiota after hematopoietic cell transplantation with glycopeptide antibiotics: potential association with pathophysiology of oral mucositis. |